Confo Therapeutics is awarded € 2.6 million in non-dilutive funding for the discovery of new fibrosis treatments and for expanding the use of its unique Confo® technology
on 01/02/2017 10:54
confo
Confo Therapeutics appoints Dr Cedric Ververken as Chief Executive Officer
on 07/09/2016 10:50
Confo Therapeutics appoints Dr Christel Menet as Chief Scientific Officer
on 10/05/2016 11:57
